Understanding how protein changes affect Alzheimer's disease
Conserved regulation of proteostasis by post-translational protein AMPylation
This study is looking at how a process called protein AMPylation might influence the stability of proteins linked to Alzheimer's disease, and it's for anyone interested in understanding more about how this condition affects brain health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10939354 on NIH RePORTER |
What this research studies
This research investigates the role of protein AMPylation in Alzheimer's disease, focusing on how this process affects the stability and aggregation of proteins associated with the disease. By using various model systems, including human cell lines and mouse models, the researchers aim to uncover the mechanisms behind protein AMPylation and its impact on brain health. The study will utilize advanced techniques to analyze protein changes in brain tissue from Alzheimer's patients, providing insights into the disease's progression.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or related dementias.
Not a fit: Patients with non-neurodegenerative conditions or those without cognitive impairment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for Alzheimer's disease by targeting protein aggregation processes.
How similar studies have performed: Previous research has shown promising results in understanding protein aggregation in neurodegenerative diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Truttmann, Matthias Christof — University of Michigan at Ann Arbor
- Study coordinator: Truttmann, Matthias Christof
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.